Cargando…

Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China

BACKGROUND AND OBJETIVES: Hyperuricemia (HUA) and gout seriously influence patients’ quality of life. The current study was performed to investigate the prevalence of HUA and gout and the related risk factors in Chinese adults. METHODS: Data were collected from the National Survey of Thyroid Disorde...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jing, Jin, Chenye, Shan, Zhongyan, Teng, Weiping, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328039/
https://www.ncbi.nlm.nih.gov/pubmed/35959454
http://dx.doi.org/10.2478/jtim-2022-0031
_version_ 1784757630784241664
author Song, Jing
Jin, Chenye
Shan, Zhongyan
Teng, Weiping
Li, Jing
author_facet Song, Jing
Jin, Chenye
Shan, Zhongyan
Teng, Weiping
Li, Jing
author_sort Song, Jing
collection PubMed
description BACKGROUND AND OBJETIVES: Hyperuricemia (HUA) and gout seriously influence patients’ quality of life. The current study was performed to investigate the prevalence of HUA and gout and the related risk factors in Chinese adults. METHODS: Data were collected from the National Survey of Thyroid Disorders and Diabetes (the Thyroid Disease, Iodine Status, and Diabetes National Epidemiological survey [TIDE]), a cross-sectional investigation conducted during 2015–2017. Using a random, multistage, and stratified sampling strategy, a representative sample (78,130 participants aged 18 years and above) was selected from the general population in 31 provinces of mainland China. The weighted prevalence rates of HUA and gout were calculated, and the related risk factors were analyzed. RESULTS: The weighted prevalence rates of HUA and gout in Chinese adults were 17.7% and 3.2%, respectively. The prevalence of HUA in males linearly decreased with age, while the prevalence in females showed the opposite trend (both P for trend < 0.01). The prevalence rate of gout exhibited a rising tendency with age in both genders (both P for trend < 0.05). The HUA and gout prevalence rates in males were the highest in Han and Tibetan nationalities, respectively. Logistic regression analysis showed that the morbidities of HUA and gout were differentially associated with age, residence location, nationality, smoking, and other complicating metabolic diseases in the two genders. CONCLUSIONS: There are relatively high prevalence rates of gout and HUA in China, which is currently a developing country. Reducing their burden has become an urgent issue for Chinese people.
format Online
Article
Text
id pubmed-9328039
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-93280392022-08-10 Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China Song, Jing Jin, Chenye Shan, Zhongyan Teng, Weiping Li, Jing J Transl Int Med Original Article BACKGROUND AND OBJETIVES: Hyperuricemia (HUA) and gout seriously influence patients’ quality of life. The current study was performed to investigate the prevalence of HUA and gout and the related risk factors in Chinese adults. METHODS: Data were collected from the National Survey of Thyroid Disorders and Diabetes (the Thyroid Disease, Iodine Status, and Diabetes National Epidemiological survey [TIDE]), a cross-sectional investigation conducted during 2015–2017. Using a random, multistage, and stratified sampling strategy, a representative sample (78,130 participants aged 18 years and above) was selected from the general population in 31 provinces of mainland China. The weighted prevalence rates of HUA and gout were calculated, and the related risk factors were analyzed. RESULTS: The weighted prevalence rates of HUA and gout in Chinese adults were 17.7% and 3.2%, respectively. The prevalence of HUA in males linearly decreased with age, while the prevalence in females showed the opposite trend (both P for trend < 0.01). The prevalence rate of gout exhibited a rising tendency with age in both genders (both P for trend < 0.05). The HUA and gout prevalence rates in males were the highest in Han and Tibetan nationalities, respectively. Logistic regression analysis showed that the morbidities of HUA and gout were differentially associated with age, residence location, nationality, smoking, and other complicating metabolic diseases in the two genders. CONCLUSIONS: There are relatively high prevalence rates of gout and HUA in China, which is currently a developing country. Reducing their burden has become an urgent issue for Chinese people. Sciendo 2022-07-07 /pmc/articles/PMC9328039/ /pubmed/35959454 http://dx.doi.org/10.2478/jtim-2022-0031 Text en © 2022 Jing Song, Chenye Jin, Zhongyan Shan, Weiping Teng, Jing Li, published by Sciendo https://creativecommons.org/licenses/by-nc-nd/3.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
spellingShingle Original Article
Song, Jing
Jin, Chenye
Shan, Zhongyan
Teng, Weiping
Li, Jing
Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China
title Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China
title_full Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China
title_fullStr Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China
title_full_unstemmed Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China
title_short Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China
title_sort prevalence and risk factors of hyperuricemia and gout: a cross-sectional survey from 31 provinces in mainland china
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328039/
https://www.ncbi.nlm.nih.gov/pubmed/35959454
http://dx.doi.org/10.2478/jtim-2022-0031
work_keys_str_mv AT songjing prevalenceandriskfactorsofhyperuricemiaandgoutacrosssectionalsurveyfrom31provincesinmainlandchina
AT jinchenye prevalenceandriskfactorsofhyperuricemiaandgoutacrosssectionalsurveyfrom31provincesinmainlandchina
AT shanzhongyan prevalenceandriskfactorsofhyperuricemiaandgoutacrosssectionalsurveyfrom31provincesinmainlandchina
AT tengweiping prevalenceandriskfactorsofhyperuricemiaandgoutacrosssectionalsurveyfrom31provincesinmainlandchina
AT lijing prevalenceandriskfactorsofhyperuricemiaandgoutacrosssectionalsurveyfrom31provincesinmainlandchina